Greg Morriello

Statistics

Publications

Citations

181

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Greg Morriello is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and growth hormone.

Publications per year

1998–2021

Publications

Solid phase synthesis of ‘head-to-tail’ cyclic peptides using a sulfonamide ‘safety-catch’ linker: the cleavage by cyclization approach

Lihu Yang, Greg Morriello · Tetrahedron Letters · 1999 · 68 citations

Natural Sciences, Biochemistry, Chemistry +12

Potent 3-spiropiperidine growth hormone secretagogues

Lihu Yang, Greg Morriello, Kristine Prendergast et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 46 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +12

1-[2(R)-(2-Amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]-3- benzylpiperidine-3(S)-carboxylic Acid Ethyl Ester (L-163,540): A Potent, Orally Bioavailable, and Short-Duration Growth Hormone Secretagogue

Lihu Yang, Greg Morriello, Arthur A. Patchett et al. · Journal of Medicinal Chemistry · 1998 · 36 citations

Medicine, Endocrinology, Pharmacology +5

Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists

Changyou Zhou, Liangqin Guo, Greg Morriello et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 17 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors

Anmol Gulati, Charles S. Yeung, Blair T. Lapointe et al. · RSC Medicinal Chemistry · 2021 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 5